← Open Payments lookup

NPI 1699914358: Open Payments

NPI 1699914358. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$417 in 16 payments from 11 companies in 2025. Trend: 2023 $416 · 2024 $593 · 2025 $417

Food & beverage: $417
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP1$114
Novo Nordisk Inc5$92
Bayer Healthcare Pharmaceuticals Inc.2$49
Tactile Systems Technology Inc1$34
ABBVIE INC.1$24
TMS NeuroHealth Centers Inc.1$21
VERTEX PHARMACEUTICALS INCORPORATED1$19
Medtronic, Inc.1$18
GlaxoSmithKline, LLC.1$16
Otsuka America Pharmaceutical, Inc.1$16

Products named: BREZTRI, Ozempic, Kerendia, Flexitouch Plus, QULIPTA, Rybelsus, TMS NeuroHealth Centers Inc., JOURNAVX.